FindTrial
Sign In

Clinical study on the role of inward rectifying potassium channel Kir2.1 in invasion and metastasis of medulloblastoma

Clinical study on the role of inward rectifying potassium channel Kir2.1 in invasion and metastasis of medulloblastoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047723
Enrollment
Unknown
Registered
2021-06-23
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medulloblastoma

Interventions

Case series:No

Sponsors

Southwest Hospital, Army Medical University, PLA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Clinical diagnosis was medulloblastoma.

Exclusion criteria

Exclusion criteria: No.

Design outcomes

Primary

MeasureTime frame
Kir2.1 expression;—

Countries

China

Contacts

Public ContactWang Yan

Southwest hospital, Army Medical University

wang_yan1977@hotmail.com+86 18323126870

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026